THERAPY OF NONALCOHOLIC FATTY LIVER DISEASE. IS THERE A PLACE FOR HEPATOPROTECTORS?


V.V. Tsukanov, A.V. Vasyutin, Yu.L. Tonkikh, O.S. Amelchugova

FGBU "Scientific Research Institute of Medical Problems of the North" SB RAMS, Krasnoyarsk
Currently, non-alcoholic fatty liver disease is the most common liver disease. Treatment of this disease includes the use of graduated exercises, diet modification, weight reduction, the use of insulin sensitizers, and drugs with cytoprotective activity, including essential phospholipids and antioxidants. The article analyzes the current data on the pathogenesis, risk factors and principles of treatment of non-alcoholic fatty liver disease (NAFLD). Methods of treatment of NAFLD develop rapidly, and it requires medical attention.

About the Autors


V.V. Tsukanov – MD, Prof., Head of the Gastroenterological Department of the FSBI SRIMPN SB RAMS; e-mail: gastro@impn.ru
A.V. Vasyutin – PhD in Medical Sciences, Senior Researcher, FSBI SRIMPN SB RAMS; e-mail: alexander@kraslan.ru
Yu.L. Tonkikh – PhD in Medical Sciences, Leading Researcher, FSBI SRIMPN SB RAMS; e-mail: tjulia@bk.ru
O.S. Amelchugova – PhD in Medical Sciences, Senior Researcher, FSBI SRIMPN SB RAMS; e-mail: am_olya@hotmail.com


Similar Articles


Бионика Медиа